Press release
Mosquito Borne Diseases Market Set to Reach $4.51 Billion by 2029 with 8% Yearly Growth
Mosquito Borne Diseases
The growth of the mosquito borne diseases market is set to be fueled by a boom in international travel. The triggers behind this uptick in global travel include a heightened desire for leisure, business, and reunion trips in the aftermath of the pandemic, complemented by better transportation infrastructure and easier access. International travel enhances the dissemination of mosquito-borne diseases by increasing contact with mosquito environments, enabling the transportation of mosquitoes carrying diseases, and impeding effective strategies for vector control. For instance, data from the Spain-based UN Tourism agency shows that from January to September 2024, there were around 1.1 billion international tourist arrivals (overnight visitors), marking an approximately 11% rise compared to the same timeframe in 2023. Consequently, this spike in international travel is a major factor propelling the mosquito borne diseases market's expansion.
Get Your Mosquito Borne Diseases Market Report Here:
https://www.thebusinessresearchcompany.com/report/mosquito-borne-diseases-global-market-report
What is the projected compound annual growth rate (CAGR) of the mosquito borne diseases market from 2025 to 2034, and what factors influence it?
The market size for diseases transmitted by mosquitoes has seen solid growth in the last few years. The market is predicted to expand from $3.06 billion in 2024 to $3.31 billion in 2025, with a compound annual growth rate (CAGR) of 8.3%. Factors contributing to the growth during the historical period include the escalating occurrences of malaria and dengue, increasing global temperatures, insufficient public health facilities, urbanization and population rise, and heightened awareness about healthcare.
The market for diseases transmitted by mosquitoes is projected to experience robust growth in the upcoming years. The market is set to expand to $4.51 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 8.0%. This growth during the forecast period is linked to multiple factors such as increased funding for vector control programs, a strengthened focus on healthcare facilities, an upsurge in travel and tourism to areas prone to the diseases, the appearance of drug-resistant mosquitoes, and government efforts towards the elimination of these diseases. The forecast period is likely to witness several trends including enhancements in vector-control methods, the creation of insecticide-treated bed nets, the launch of rapid diagnostic test kits, technological advancements, and the invention of advanced diagnostic tools.
Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20888&type=smp
How are the latest trends influencing the growth of the mosquito borne diseases market?
Leading businesses in the market for mosquito-carried illnesses are prioritizing the creation of groundbreaking products, like enhanced mosquito deterrents, to improve the level of defense against diseases such as malaria, dengue, and Zika. Enhanced mosquito deterrents include revolutionary products that utilize enduring, effective compounds or technologies, such as microencapsulation, organic elements, or wearable gadgets, to deliver augmented protection from mosquitoes. For example, in March 2023, Mortein, a household insecticide brand based in Australia, introduced to the market the Mortein Smart+, an innovative liquid vaporizer specifically designed to shield against mosquitoes. This product yields two hours of lingering protection even when it's turned off, responding to the increased risk of mosquito-carried diseases with quicker and more potent repellency. The unveiling of this product reinforces Mortein's commitment to providing dependable solutions for households, especially in the battle against diseases carried by mosquitoes.
What are the major segments of the mosquito borne diseases market and their role in driving growth?
The mosquito borne diseases market covered in this report is segmented -
1) By Disease Type: Malaria, Dengue, Yellow Fever, West Nile Virus, Chikungunya, Zika Virus, Other Disease Types
2) By Treatment Type: Medication, Vaccination, Vector Control Methods, Immunotherapy, Supportive Care, Other Treatment Types
3) By End User: Hospitals, Clinics, Diagnostic Centers, Research Institutes, Government Organizations, Non-Governmental Organizations, Other End Users
Subsegments:
1) By Malaria: Plasmodium Falciparum Malaria, Plasmodium Vivax Malaria, Other Malaria Types
2) By Dengue: Dengue Fever, Severe Dengue (Dengue Hemorrhagic Fever)
3) By Yellow Fever: Acute Yellow Fever, Chronic Yellow Fever
4) By West Nile Virus: Neuroinvasive Disease (Encephalitis, Meningitis), Non-neuroinvasive Disease
5) By Chikungunya: Acute Chikungunya, Chronic Chikungunya
6) By Zika Virus: Acute Zika Infection, Congenital Zika Syndrome
7) By Other Disease Types: Japanese Encephalitis, La Crosse Encephalitis, Eastern Equine Encephalitis (EEE), Other Mosquito-Borne Infections
Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20888
Which regions are key players in the growth of the mosquito borne diseases market?
North America was the largest region in the mosquito borne diseases market in 2024. Latin America is expected to be the fastest-growing region in the forecast period. The regions covered in the mosquito borne diseases market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Who are the key firms paving the way for growth in the mosquito borne diseases market?
Major companies operating in the mosquito borne diseases market are Johnson & Johnson, Merck & Co. Inc., Sanofi S.A., Abbott Laboratories, Novartis AG, GlaxoSmithKline plc, Syngenta, Takeda Pharmaceuticals, Eisai Co. Ltd., Sun Pharmaceutical Industries Ltd., Serum Institute of India Pvt. Ltd., Orkin Inc., RTI International, Emergent BioSolutions, Valneva SE, BioCryst Pharmaceuticals Inc., Bharat Biotech, Vector Control International, Clarke Environmental Mosquito Management, Inovio Pharmaceuticals, Oxitec Ltd.
Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/customise?id=20888&type=smp
What Is Covered In The Mosquito Borne Diseases Global Market Report?
•Market Size Forecast: Examine the mosquito borne diseases market size across key regions, countries, product categories, and applications.
•Segmentation Insights: Identify and classify subsegments within the mosquito borne diseases market for a structured understanding.
•Key Players Overview: Analyze major players in the mosquito borne diseases market, including their market value, share, and competitive positioning.
•Growth Trends Exploration: Assess individual growth patterns and future opportunities in the mosquito borne diseases market.
•Segment Contributions: Evaluate how different segments drive overall growth in the mosquito borne diseases market.
•Growth Factors: Highlight key drivers and opportunities influencing the expansion of the mosquito borne diseases market.
•Industry Challenges: Identify potential risks and obstacles affecting the mosquito borne diseases market.
•Competitive Landscape: Review strategic developments in the mosquito borne diseases market, including expansions, agreements, and new product launches.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mosquito Borne Diseases Market Set to Reach $4.51 Billion by 2029 with 8% Yearly Growth here
News-ID: 3943584 • Views: …
More Releases from The Business Research Company
Key Drivers Reshaping the Purvalanol A (CDK Inhibitor) Market: Increasing Preval …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Purvalanol A (CDK Inhibitor) Market Size Growth Forecast: What to Expect by 2025?
The market size for purvalanol A (CDK inhibitor) has witnessed a substantial expansion in the past few years. It is projected to escalate from $0.58 billion in 2024 to $0.64 billion in 2025, with a compound…
Growing Emphasis On Personalized Medicine Driving The Market Due To Advances In …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Polygenic Risk Score Services Market Size Growth Forecast: What to Expect by 2025?
The market size for polygenic risk score services has seen considerable growth in recent years. Anticipated to increase from $1.24 billion in 2024 to $1.45 billion in 2025, it projects a compound annual growth rate (CAGR)…
Future of the Global Pharmaceutical Unit-Dose Packaging Market: Trends, Innovati …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Pharmaceutical Unit-Dose Packaging Market Size Growth Forecast: What to Expect by 2025?
The market size of the pharmaceutical unit-dose packaging industry has experienced quick expansion in the recent past. The market, valued at $48.78 billion in 2024, is projected to rise to $54.50 billion in 2025, reflecting a compound…
Personal Care Product Testing Market Poised to Hit $10.37 Billion by 2029 with A …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Personal Care Product Testing Market Size Growth Forecast: What to Expect by 2025?
In the past few years, the market size for personal care product testing has seen robust growth. It's projected to increase from $7.28 billion in 2024 to $7.84 billion in 2025, with a compound annual growth…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
